MedTrace Logo

A Post-Market Clinical Follow Up Study to Evaluate BD PureHub™ Disinfecting Cap Use on Needle-Free Connectors

NCT05130762 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 157

Last updated 2025-01-27

Study results available
· View outcomes & findings →

Summary

The study will collect use data of the Becton Dickinson (BD) PureHub™ Disinfecting Cap in combination with needle-free connectors, which are attached to vascular access devices (VAD).

Conditions

  • Catheter Related Complication
  • Vascular Access Site Management
  • Disinfecting Cap

Interventions

DEVICE

BD PureHub™ Disinfecting Cap Placements: Attachments/removals

Attachment/Removals of BD PureHub™ Disinfecting Cap

Sponsors & Collaborators

  • Becton, Dickinson and Company

    lead INDUSTRY

Study Design

Allocation
NA
Purpose
OTHER
Masking
NONE
Model
SINGLE_GROUP

Eligibility

Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2022-01-31
Primary Completion
2023-05-22
Completion
2023-05-22

Countries

  • Austria
  • Belgium
  • Italy
  • Spain

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05130762 on ClinicalTrials.gov